Fundraising FoxOncoMed Website
Acquired2 known investors
Find your way into OncoMed Website
Sign up to see every warm intro you have to OncoMed Website
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OncoMed Website team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mereo BioPharma is a rare disease drug developer that funds and advances novel therapeutic candidates not progressed by their originating pharmaceutical or biotech companies, with lead programs in osteogenesis imperfecta and Alpha-1 Antitrypsin Deficiency-associated Lung Disease. It operates a capital-efficient model, retaining regional development rights while forming strategic partnerships, and collaborates with patient communities in the rare disease space.
Investors · 2
Frequently asked questions
- What does OncoMed Website do?
- Mereo BioPharma is a rare disease drug developer that funds and advances novel therapeutic candidates not progressed by their originating pharmaceutical or biotech companies, with lead programs in osteogenesis imperfecta and Alpha-1 Antitrypsin Deficiency-associated Lung Disease. It operates a capital-efficient model, retaining regional development rights while forming strategic partnerships, and collaborates with patient communities in the rare disease space.
- Who are OncoMed Website's investors?
- OncoMed Website's investors include Latterell Venture Partners, The Vertical Group.